Tag Archives: Drug

Transparency by drug companies, scrutiny by journalists, vital in vaccine news

Pfizer’s chairman and CEO proclaimed in a Pfizer company news release: “Today is a great day for science and humanity.” In that PR news release – but only in that format – Pfizer announced early results of “a vaccine efficacy rate above 90%, at 7 days after the second dose.” That’s about all we know… Read More »

After Pfizer’s vaccine data, analysts say COVID drug makers face questions about long-term sales prospects

While much of the world focused on Pfizer and BioNTech’s positive COVID-19 vaccine news on Monday, analysts started gaming out potential ripple effects, namely for companies making coronavirus therapeutics. A promising COVID-19 vaccine is obviously good news for drugmakers and the world at large, but companies developing and selling coronavirus treatments could see lower sales down the line, Barclays analysts wrote… Read More »

Could an Antibody Drug Help You Shed Pounds?

MONDAY, Nov. 2, 2020 — An experimental antibody drug that targets one of the body’s key metabolism regulators may help obese people lose weight — at least briefly. That’s one finding from an early study that tested the injection drug, which mimics the effects of a natural hormone called fibroblast growth factor 21 (FGF21). In… Read More »

New drug prolongs ALS patient survival in trial

An experimental medication that was recently shown to slow the progression of the neurodegenerative disease amyotrophic lateral sclerosis (ALS) has now demonstrated the potential to also prolong patient survival. The findings come from a clinical trial conducted by investigators at the Sean M. Healey & AMG Center for ALS at Harvard-afilliated Massachusetts General Hospital (MGH)… Read More »